Impaired Insulin Secretion in Human Diabetes Mellitus: The Effect of Naloxone-Induced Opiate Receptor Blockade
The DOI matches its Crossref record.
Abstract
Human diabetes mellitus is characterized by impaired insulin response to intravenous glucose. In search of possible factors which impair insulin release, we have investigated the effect of naloxone, a specific opiate receptor blocker, on insulin responses to glucose in subjects with non-insulin-dependent diabetes, as well as in normal subjects. Naloxone was given as a priming dose of 0.4 mg followed by a constant infusion of either 0.4 mg (N = 7), 2 mg (N = 7), or 4 mg (N = 8) for 90 min. Acute insulin response to glucose (mean change 3–10 min insulin), second phase insulin secretion (change 10–60 min), as well as glucose disappearance rates (﹪/min) were significantly increased in the diabetics receiving the two higher doses of naloxone (2 and 4 mg, respectively). None of these effects were seen in diabetics receiving saline or in normal subjects receiving naloxone. These results seem to suggest that sensitivity to endogenous opiates may play some part in non-insulin-dependent diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Huang, G., Travison, T., Maggio, M., Edwards, R. R., & Basaria, S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13049 · Cited by 26
Metadata
- Authors
- Giugliano, D., Ceriello, A., Pinto, P. D., Saccomanno, F., Gentile, S., & Cappiapuoti, F.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1982-04-01
- Volume
- 31
- Issue
- 4
- Pages
- 367-370
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2148442997
- Cited by
- 41
- References
- 0
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.